NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
Clinical Trials
5 trialsNCT02555748 2021-01-12
SUP-R
Institut Claudius Regaud
Phase 4 Completed
NCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00930345 2015-04-01
PREINSUT
Assistance Publique - Hôpitaux de Paris
Phase 4 Terminated
NCT00706706 2013-01-18
MRCC RCC
Pfizer
Phase 4 Completed